2,4-二羟基-3-(p-甲氧基苯基)-苯丙酮 | 93435-21-3

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 中文名称: 2,4-二羟基-3-(p-甲氧基苯基)-苯丙酮
• 英文名称: 2',4'-dihydroxy-4-methoxydihydrochalcone
• 英文别名: 4-O-methyldavidigenin；2',4'-Dihydroxy-3-(p-methoxyphenyl)-propiophenone；1-(2,4-dihydroxyphenyl)-3-(4-methoxyphenyl)propan-1-one
• CAS: 93435-21-3
• 化学式: C₁₆H₁₆O₄
• 分子量: 272.301
• InChiKey: WHIXVXRRHPHWRQ-UHFFFAOYSA-N

物化性质

• 熔点：
  83 °C
• 沸点：
  491.4±24.0 °C(Predicted)
• 密度：
  1.243±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2914509090

反应信息

• 作为反应物：
  描述：

  2,4-二羟基-3-(p-甲氧基苯基)-苯丙酮 在 吡啶 、 高氯酸 作用下， 以 二氯甲烷 为溶剂， 反应 5.17h， 生成 3-(4-methoxybenzyl)-4-oxo-4H-chromen-7-yl (9Z)-oleate
  参考文献：
  名称：

  Synthesis and biological evaluation of new flavonoid fatty acid esters with anti-adipogenic and enhancing glucose consumption activities

  摘要：

  Oleoyl Formononetin (OF) has good weight loss activity and hypolipidemic activity, could improve insulin sensitivity and suppress adipogenesis. To acquire better biological activities, three series of flavonoid fatty acid esters were designed and synthesized by optimizing the structure of OF. Their bioactivities were assayed in vitro. Some of these novel compounds could effectively inhibit preadipocyte proliferation and adipogenesis. Moreover, they could enhance glucose consumption in adipocytes notably. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.03.063
• 作为产物：
  描述：

  4-甲氧基肉桂酸 在 palladium 10% on activated carbon 、 三氟化硼乙醚 、 氢气 作用下， 以 四氢呋喃 为溶剂， 反应 6.5h， 生成 2,4-二羟基-3-(p-甲氧基苯基)-苯丙酮
  参考文献：
  名称：

  Synthesis and biological evaluation of new flavonoid fatty acid esters with anti-adipogenic and enhancing glucose consumption activities

  摘要：

  Oleoyl Formononetin (OF) has good weight loss activity and hypolipidemic activity, could improve insulin sensitivity and suppress adipogenesis. To acquire better biological activities, three series of flavonoid fatty acid esters were designed and synthesized by optimizing the structure of OF. Their bioactivities were assayed in vitro. Some of these novel compounds could effectively inhibit preadipocyte proliferation and adipogenesis. Moreover, they could enhance glucose consumption in adipocytes notably. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.03.063

文献信息

• Synthesis and Insight into the Structure–Activity Relationships of Chalcones as Antimalarial Agents
  作者：Narender Tadigoppula、Venkateswarlu Korthikunta、Shweta Gupta、Papireddy Kancharla、Tanvir Khaliq、Awakash Soni、Rajeev Kumar Srivastava、Kumkum Srivastava、Sunil Kumar Puri、Kanumuri Siva Rama Raju、Wahajuddin、Puran Singh Sijwali、Vikash Kumar、Imran Siddiqi Mohammad

  DOI：10.1021/jm300588j

  日期：2013.1.10

  licorice, is the most promising antimalarial compound reported so far. In continuation of our drug discovery program, we isolated two similar chalcones, medicagenin (II) and munchiwarin (III), from Crotalaria medicagenia, which exhibited antimalarial activity against Plasmodium falciparum. A library of 88 chalcones were synthesized and evaluated for their in vitro antimalarial activity. Among these, 67,

  从中国甘草的根中分离得到的Licochalcone A（I）是迄今为止报道的最有前途的抗疟化合物。在继续我们的药物发现计划时，我们从猪屎豆属中分离了两个类似的查耳酮，medicageninin（II）和munchiwarin（III），它们对恶性疟原虫具有抗疟活性。合成了88个查耳酮的文库，并对其体外抗疟活性进行了评估。在这些中，67，68，74，77，和78显示出在体外对抗疟疾活性良好恶性疟原虫具有低细胞毒性的3D7和K1菌株。这些查耳酮还显示出寄生虫约瑟氏疟原虫（N-67株）感染的瑞士小鼠的寄生虫病减少和存活时间增加。药代动力学研究表明，不良的ADME特性导致口服生物利用度低。分子对接研究揭示了这些抑制剂在falcipain-2（FP-2）酶的活性位点的结合方向。化合物67，68，和78显示出对主要血红蛋白降解半胱氨酸适度抑制活性蛋白酶FP-2。
• METHODS OF DESIGNING, PREPARING, AND USING NOVEL PROTONOPHORES
  申请人：Martineau Louis C.

  公开号：US20140135359A1

  公开（公告）日：2014-05-15

  The present invention provides a computer-assisted method of generating a protonophore requiring the use of a computer including a processor. The method includes: designing the protonophore, calculating, using the processor, an estimated protonophoric activity; producing the protonophore if the estimated protonophoric activity corresponds to an U 50 of about 20 μM or less; and determining the uncoupling activity of the protonophore. The present invention also provides novel protonophores that meet the above requirement and their methods of use.

  本发明提供了一种利用计算机辅助的方法来生成需要使用处理器的质子载体。该方法包括：设计质子载体，使用处理器计算估计的质子载体活性；如果估计的质子载体活性对应于大约20微米或更少的U50，则生产质子载体；并确定质子载体的解耦活性。本发明还提供了符合上述要求的新型质子载体及其使用方法。
• A concise synthesis of polyhydroxydihydrochalcones and homoisoflavonoids
  作者：Vidavalur Siddaiah、Chunduri Venkata Rao、Somepalli Venkateswarlu、Gottumukkala V. Subbaraju

  DOI：10.1016/j.tet.2005.10.059

  日期：2006.1

  phloretin and 5,7-dihydroxy-3-[(4-hydroxyphenyl)methyl]-4H-chromen-4-one. The antioxidant activity of dihydrochalcones and homoisoflavonoids was determined by superoxide free radical (NBT) and DPPH free radical scavenging methods. Polyhydroxydihydrochalcones 3c, 3f, 3g and homoisoflavonoids 4c, 4f, 4g displayed excellent antioxidant activity.

  描述了使用BF 3 ·Et 2 O从容易获得的苯酚和二氢肉桂酸中一般一步合成多羟基二氢查耳酮的方法。该方法允许合成具有多种酚羟基和其他取代基的多种化合物。这些二氢查耳酮通过DMF / PCl 5转化为同型异黄酮，该方法已应用于合成天然的伞菌素和5,7-二羟基-3-[（4-羟基苯基）甲基] -4 H-色氨酸-4-酮。通过超氧自由基（NBT）和清除DPPH自由基的方法测定了二氢查耳酮和同型异黄酮的抗氧化活性。聚羟基二氢查耳酮3c，3f，3g和均异黄酮类化合物4c，4f和4g显示出极好的抗氧化活性。
• [EN] COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES<br/>[FR] COMPOSITIONS ET PROCÉDÉS DE TRAITEMENT DE MALADIES ASSOCIÉES AU SYSTÈME UBIQUITINE/PROTÉASOME
  申请人：UNIV LOUISIANA STATE

  公开号：WO2022015740A1

  公开（公告）日：2022-01-20

  This invention is directed to methods of treating disease characterized by aberrations in the ubiquitin proteasome system (UPS).

  本发明是针对具有泛素蛋白酶体系统（UPS）异常的疾病的治疗方法。
• USE OF 1-(2,4-DIHYDROXY-PHENYL)-3-(3-HYDROXY-4-METHOXY-PHENYL)-PROPAN-1-ONE
  申请人：Backes Michael

  公开号：US20110189108A1

  公开（公告）日：2011-08-04

  The invention concerns the use of a deoxy hesperetin dihydrochalcone or a salt of the deoxy hesperetin dihydrochalcone (I) or a mixture comprising or consisting of a plurality of salts of the deoxy hesperetin dihydrochalcone (I) or a mixture comprising or consisting of deoxy hesperetin dihydrochalcone (I) and a salt or a plurality of salts of the deoxy hesperetin dihydrochalcone (I), to influence the strength of taste impressions of sweet-tasting, unpleasant-, in particular bitter-, tasting or both sweet- and unpleasant-, in particular bitter-, tasting substances or mixtures of substances.

  本发明涉及使用脱氧异柚皮素二氢黄酮或脱氧异柚皮素二氢黄酮的盐（I），或包含或由多种脱氧异柚皮素二氢黄酮（I）的盐组成或构成的混合物，或包含或由脱氧异柚皮素二氢黄酮（I）和脱氧异柚皮素二氢黄酮（I）的一个或多个盐组成或构成的混合物，来影响甜味、不愉快-尤其是苦味-或同时甜味和不愉快-尤其是苦味-的物质或物质混合物的味道强度。